CD79A and Alzheimer disease: We speculated that the simultaneous decreases in anti-Gal IgM and IgG and the increase in anti-Gal IgA we observed in AD patients might reflect the class switching of anti-α-Gal B cells from the production of “natural” IgM antibodies to an IgA-mediated adaptive response.